These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26844509)

  • 1. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
    Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
    Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio predicts recurrence in papillary thyroid cancer.
    Schneider DF; Mazeh H; Chen H; Sippel RS
    Oncologist; 2013; 18(2):157-62. PubMed ID: 23345543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
    Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
    J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
    Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
    Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
    Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
    Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
    Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
    Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
    Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
    Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study.
    Hwangbo Y; Kim JM; Park YJ; Lee EK; Lee YJ; Park DJ; Choi YS; Lee KD; Sohn SY; Kim SW; Chung JH; Lim DJ; Kim MH; Kim MJ; Jo YS; Shong MH; Koong SS; Hahm JR; Jung JH; Yi KH
    J Clin Endocrinol Metab; 2017 Feb; 102(2):625-633. PubMed ID: 27732329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
    Kang JG; Choi JE; Kang SH
    World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.
    Kang IK; Kim K; Park J; Bae JS; Kim JS
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.
    Luo Z; Hei H; Qin J; Zheng C; Gong W
    Endocrine; 2022 Dec; 78(3):484-490. PubMed ID: 36018538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.
    Luo Z; Hei H; Qin J; Zheng C; Gong W; Zhou B
    Langenbecks Arch Surg; 2023 Aug; 408(1):315. PubMed ID: 37584830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
    Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
    J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.